Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Ocean Genomics
Ellumigen, formerly Ocean Genomics, offers an AI-powered, end-to-end translational multi-omics platform called Ellumigen Breakthrough™. This platform transforms raw sequencing and curated study data…
Ocean Genomics
Ellumigen, formerly Ocean Genomics, offers an AI-powered, end-to-end translational multi-omics platform called Ellumigen Breakthrough™. This platform transforms raw sequencing and curated study data…
TL;DR
Sector: Biotechnology — transcriptome / gene expression analytics
Product: AI-powered translational multi-omics platform (Ellumigen Breakthrough™)
Founding year: 2018
Founders: Carl Kingsford; Eric V. Schultz; Robert Patro
Investors: Accenture Ventures; BIRD Foundation
Company Overview
Problem Domain
Gene expression / transcriptome analytics, biomarker discovery, and translational multi-omics data interpretation for research and clinical applications.
Founded
2018
Industry
Biotechnology
Funding Track Record
Reported grant funding activity on public profiles.
Listed as a disclosed investor on public profiles.
Investor Signal
“Strategic investor participation (Accenture Ventures) and grant support (BIRD Foundation)”